From 1 September 2025, access to KALYDECO (ivacaftor) has been expanded under the Pharmaceutical Benefits Scheme (PBS), making this life-changing treatment available to patients aged...

On August 22 it was announced that the Pharmaceutical Benefits Advisory Committee (PBAC) deferred their recommendation on Alyftrek as the Therapeutic Goods Administration (TGA) approval...

Karrawang Community Playgroup The LungSmart team was invited to a local playgroup in the Kurrawang community to share lung health messages through storytelling and engaging...

The LungSmart team took part in the Binar Health Embassy in Derby and Perth, using basketball to share messages about chronic wet cough.  In Derby,...